טוען...
Beyond first-line chemotherapy for advanced pancreatic cancer: An expanding array of therapeutic options?
While an increasing number of therapeutic options are now available for the first-line treatment of locally advanced or metastatic pancreatic cancer, the optimal choice for treatment in the second-line setting and beyond is less well defined. A variety of cytotoxic agents, either alone or in combina...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Co., Limited
2014
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3942828/ https://ncbi.nlm.nih.gov/pubmed/24605022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i9.2224 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|